You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histiocytic Sarcoma

Showing 1 - 25 of 1,155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Histiocytic Disorder Follow-up Study

Recruiting
  • Histiocytosis
  • +5 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 13, 2023

    Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

    Active, not recruiting
    • Langerhans Cell Histiocytosis (LCH)
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 26, 2022

    Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma Trial in Chicago, Boston, Omaha (Pembrolizumab)

    Suspended
    • Lymphoma
    • +3 more
    • Chicago, Illinois
    • +3 more
    Jan 30, 2023

    Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease Trial in Memphis, Houston (Cobimetinib)

    Recruiting
    • Langerhan's Cell Histiocytosis
    • +6 more
    • Phoenix, Arizona
    • +6 more
    Jan 12, 2023

    Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

    Unknown status
    • Sarcoma
    • +16 more
    • Sequential chemotherapy - 3 courses of AI
    • Hypofractionated radiotherapy
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 19, 2021

    Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +108 more
    Oct 19, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +37 more
    • Birmingham, Alabama
    • +171 more
    Aug 24, 2022

    Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023

    Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

    Recruiting
    • Malignant Solid Neoplasm
    • +26 more
    • Birmingham, Alabama
    • +121 more
    Aug 24, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +32 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +124 more
    Aug 24, 2022

    Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Puerto Rico, United States (Ivosidenib)

    Recruiting
    • Recurrent Ependymoma
    • +32 more
    • Birmingham, Alabama
    • +173 more
    Jan 27, 2023

    Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +30 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +123 more
    Aug 23, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +113 more
    Jun 28, 2022

    Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

    Recruiting
    • Malignant Solid Neoplasm
    • +40 more
    • Biospecimen Collection
    • +6 more
    • Birmingham, Alabama
    • +172 more
    Jan 27, 2023

    Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)

    Not yet recruiting
    • Langerhans Cell Histiocytosis (LCH)
    • +3 more
    • (no location specified)
    Nov 22, 2023

    Precision Medicine for Every Child With Cancer

    Recruiting
    • Childhood Cancer
    • +5 more
    • Whole Genome Sequencing
    • +6 more
    • Adelaide, Australia
    • +8 more
    Jan 24, 2023

    Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in

    Active, not recruiting
    • Rare Histiocytic Disorders (RHDs)
    • +7 more
    • Registry study
    • Los Angeles, California
    • +13 more
    Dec 13, 2022

    Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

    Recruiting
    • Recurrent Histiocytic and Dendritic Cell Neoplasm
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 5, 2022

    Chronic Histiocytic Intervillositis, Intrauterine Growth Retardation, Fetal Death in Utero Trial in Clamart (Biological

    Not yet recruiting
    • Chronic Histiocytic Intervillositis
    • +3 more
    • Biological collection
    • Clamart, France
      Antoine Béclère Hospital
    Jun 30, 2023

    Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)

    Active, not recruiting
    Has Results
    • Langerhans Cell Histiocytosis
    • Phoenix, Arizona
    • +14 more
    Mar 28, 2022

    Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

    Active, not recruiting
    • Sarcoma, Soft Tissue
    • Changsha, Hunan, China
      Xiangya Hospital Central South University
    Oct 29, 2023

    Obstetrical History and Anti-HLA Antibodies Level

    Not yet recruiting
    • Blood Donors
    • Anti-HLA Antibody
    • Obstetrical history
    • Anti-HLA Antibody tests
    • Bordeaux, France
      Etablissement Français du Sang Nouvelle Aquitaine
    Aug 25, 2023

    Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

    Completed
    • Objective Response
    • Overall Survival
    • VIA combination treatment
    • Beijing, China
      Peking University People's Hospital
    Dec 9, 2022

    Metastatic Sarcoma, Sarcoma Trial in Seattle (Assessment, Questionnaire Administration, Interview)

    Not yet recruiting
    • Metastatic Sarcoma
    • Sarcoma
    • Assessment
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Apr 27, 2023